Register for email alerts and news feeds:
This journal | BMJ Group
rss
Evidence-Based Mental Health 2004;7:106; doi:10.1136/ebmh.7.4.106
Copyright © 2004 by BMJ Publishing Group Ltd, Royal College of Psychiatrists, & British Psychological Society.
Evidence-Based Mental Health 2004; 7:106
© 2004 BMJ Publishing Group Ltd., Royal College of Psychiatrists, & British Psychological Society

Therapeutics

Review: high doses of antipsychotic drugs are no more or less effective than medium doses in people with schizophrenia

Davis JM, Chen N. Dose response and dose equivalence of antipsychotics. J Clin Psychopharmacol 2004;24:192–208.[CrossRef][Medline]

Q Which doses of atypical and typical antipsychotic drugs produce a near maximal response with minimal side effects in people with schizophrenia or schizoaffective disorder?

The first 150 words of the full text of this article appear below.

METHODS

{ebmhflochart.f1}Design: Systematic review with meta-analysis.

{ebmhcmptrbooks.f1}Data sources: MEDLINE, International Pharmaceutical Abstracts, CINAHL, PsycINFO, and the Cochrane Database of Systematic Reviews. Hand searches of reference lists plus data from Food and Drug Administration website, poster presentations, unpublished data from Cochrane reviews, conference abstracts, and manuscripts submitted for publication. Search date: December 2002.

{ebmhmgnfyglas.f1}Study selection and analysis: Double blind, randomised controlled trials of people with schizophrenia or schizoaffective disorder comparing two or more doses of typical or atypical antipsychotics were eligible. Dose response curves were plotted and the median effective dose, defined as 50% of the maximum response (ED50), and the near maximal effective dose range (ED85 to ED95) was established for each drug. Estimated equivalent doses were based on ED50. Meta-analysis determined whether medium and high doses vary in efficacy. The last-observation-carried-forward method and intent-to-treat sample were used for the meta-analysis. The possibility of other biases was explored . . . [Full text of this article]

Scott W Woods, MD

Professor of Psychiatry, Yale University School of Medicine, New Haven,
CT, USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Online Education

Psychiatry CPD/CME from The Royal College of Psychiatrists

Professional Development from The British Psychological Society